UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Hormones of adipose tissue and their biologic role in lung cancer

Cancer treatment reviews, 2014-02, Vol.40 (1), p.22-30

2014

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80 (2), p.120-130

2013

Volltextzugriff (PDF)

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer

Annals of oncology, 2010-03, Vol.21 (3), p.556-561

2010

Volltextzugriff (PDF)

39P USEFULNESS OF ENDOBRONCHIAL ULTRASOUND IN THE DIAGNOSIS OF PERIPHERAL PULMONARY LESIONS IN A GENERAL HOSPITAL

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S17-S17

2013

Volltextzugriff (PDF)

111P EFFECTIVENESS OF MESOTHELIN FAMILY PROTEINS AND OSTEOPONTIN FOR MALIGNANT MESOTHELIOMA

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S47-S48

2013

Volltextzugriff (PDF)

Hypersensitivity To Docetaxel: Retrospective Study And Desensitization Protocol

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB104-AB104

2012

Volltextzugriff (PDF)

42P THE PREDICTIVE SIGNIFICANCE OF LEPTIN, ADIPONECTIN, RESISTIN AND GHRELIN SERUM LEVELS AT DIAGNOSIS OF PATIENTS WITH SMALL CELL LUNG CANCER

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S19-S19

2013

Volltextzugriff (PDF)

Anaphylactic Reaction To Intravenous Administration Of Folinic Acid: A Case Report

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB185-AB185

2012

Volltextzugriff (PDF)

Cisplatin can be Safely Administered After Hypersensitivity to Carboplatin

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB193-AB193

2011

Volltextzugriff (PDF)

189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer

Annals of oncology, 2022-04, Vol.33, p.S117-S117

2022

Volltextzugriff (PDF)

Circulating Biomarkers in Non-Small Cell Lung Cancer: Current Status and Future Challenges

Clinical lung cancer, 2016-11, Vol.17 (6), p.507-516

2016

Volltextzugriff (PDF)

PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)

Thrombosis research, 2022-05, Vol.213, p.S29-S29

2022

Volltextzugriff (PDF)

PO-15: Tinzaparin: a safe choice for lung cancer with VTE and renal impairment

Thrombosis research, 2022-05, Vol.213, p.S17-S18

2022

Volltextzugriff (PDF)

Central-line-associated bloodstream infections, multi-drug-resistant bacteraemias and infection control interventions: a 6-year time-series analysis in a tertiary care hospital in Greece

The Journal of hospital infection, 2022-05, Vol.123, p.27-33

2022

Volltextzugriff (PDF)

PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients

Thrombosis research, 2022-05, Vol.213, p.S29-S29

2022

Volltextzugriff (PDF)

9045 Serum metastin is not involved in metastatic potential of non-small cell lung cancer (NSCLC)

European journal of cancer supplements, 2009, Vol.7 (2), p.519-519

2009

Volltextzugriff (PDF)

Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery

European journal of cancer (1990), 2001-12, Vol.37 (18), p.2392-2397

2001

Volltextzugriff (PDF)

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis and systemic relapse

British journal of oral & maxillofacial surgery, 2007, Vol.45 (8), p.e2-e3

2007

Volltextzugriff (PDF)

Quality of Life (Qol) Results from the Phase 3 Revel Study of Ramucirumab + Docetaxel (Ram + Dtx) Versus Placebo + Docetaxel (Pl + Dtx) in Advanced/Metastatic Nsclc Patients (Pts) with Progression After Platinum Based Chemotherapy

Annals of oncology, 2014-09, Vol.25, p.iv445

2014

Volltextzugriff (PDF)

A Randomized, Open-Label, Phase III Trial of Afatinib (A) Vs Erlotinib (E) As Second-Line Treatment of Patients (Pts) with Advanced Squamous Cell Carcinoma (Scc) of the Lung Following First-Line Platinum-Based Chemotherapy: Lux-Lung 8 (Ll8)

Annals of oncology, 2014-09, Vol.25, p.iv426

2014

Volltextzugriff (PDF)

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

Annals of oncology, 2011-04, Vol.22 (4), p.827-834

2011

Volltextzugriff (PDF)

Pharmacogenetics and biomarkers in colorectal cancer

The pharmacogenomics journal, 2009-06, Vol.9 (3), p.147-160

2009

Volltextzugriff (PDF)

Overexpression of hnRNPA2/B1 in Bronchoscopic Specimens: A Potential Early Detection Marker in Lung Cancer

Anticancer research, 2009-04, Vol.29 (4), p.1373-1382

2009

Volltextzugriff (PDF)

ALTERED gamma-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER CANCER

The Journal of urology, 1998-11, Vol.160 (5), p.1889-1893

1998

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(19)
Biological And Medical Sciences
(14)
Male
(14)
Medical Sciences
(14)
Female
(13)
Oncology
(13)
Aged
(12)
Middle Aged
(9)
Adult
(8)
Hematology, Oncology And Palliative Medicine
(7)
Prognosis
(7)
Aged, 80 And Over
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Lung Neoplasms - Pathology
(5)
Pharmacology. Drug Treatments
(5)
Pneumology
(5)
Pulmonary/respiratory
(5)
Tumors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hormones of adipose tissue and their biologic role in lung cancer

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer

39P USEFULNESS OF ENDOBRONCHIAL ULTRASOUND IN THE DIAGNOSIS OF PERIPHERAL PULMONARY LESIONS IN A GENERAL HOSPITAL

111P EFFECTIVENESS OF MESOTHELIN FAMILY PROTEINS AND OSTEOPONTIN FOR MALIGNANT MESOTHELIOMA

Hypersensitivity To Docetaxel: Retrospective Study And Desensitization Protocol

42P THE PREDICTIVE SIGNIFICANCE OF LEPTIN, ADIPONECTIN, RESISTIN AND GHRELIN SERUM LEVELS AT DIAGNOSIS OF PATIENTS WITH SMALL CELL LUNG CANCER

Anaphylactic Reaction To Intravenous Administration Of Folinic Acid: A Case Report

Cisplatin can be Safely Administered After Hypersensitivity to Carboplatin

189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer

Circulating Biomarkers in Non-Small Cell Lung Cancer: Current Status and Future Challenges

PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)

PO-15: Tinzaparin: a safe choice for lung cancer with VTE and renal impairment

Central-line-associated bloodstream infections, multi-drug-resistant bacteraemias and infection control interventions: a 6-year time-series analysis in a tertiary care hospital in Greece

PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients

9045 Serum metastin is not involved in metastatic potential of non-small cell lung cancer (NSCLC)

Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis and systemic relapse

Quality of Life (Qol) Results from the Phase 3 Revel Study of Ramucirumab + Docetaxel (Ram + Dtx) Versus Placebo + Docetaxel (Pl + Dtx) in Advanced/Metastatic Nsclc Patients (Pts) with Progression After Platinum Based Chemotherapy

Prognostic Significance of Tumour-Associated Immune Response Gene Expression, Esr1 and Clinicopathologic Parameters in Stage Ii/Iii Colorectal Cancer: a Translational Research Study of the Hellenic Cooperative Oncology Group (Hecog)

A Randomized, Open-Label, Phase III Trial of Afatinib (A) Vs Erlotinib (E) As Second-Line Treatment of Patients (Pts) with Advanced Squamous Cell Carcinoma (Scc) of the Lung Following First-Line Platinum-Based Chemotherapy: Lux-Lung 8 (Ll8)

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

Pharmacogenetics and biomarkers in colorectal cancer

Overexpression of hnRNPA2/B1 in Bronchoscopic Specimens: A Potential Early Detection Marker in Lung Cancer

ALTERED gamma-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER CANCER

Suchergebnisse filtern